top of page

Neodocs Raises $2 Million to Expand Smartphone-Based Health Test Kits Globally

Mumbai-based healthtech startup Neodocs has secured $2 million in a seed funding round led by prominent investors including Omidyar Network India, Y Combinator, and 9 Unicorns, among others.


Specializing in the development of smartphone-based health test kits, Neodocs offers users the convenience of conducting various health tests from their homes using only their smartphones and a test card.


Expanding Product Lineup and International Presence

With the latest funding, Neodocs aims to bolster its product lineup, with a particular focus on its kidney care and urinary tract infections (UTI) kits. Additionally, the startup has introduced a new product—an instant finger-prick blood test that delivers rapid results directly to users' smartphones.


The infusion of capital will fuel Neodocs' expansion into international markets, including Europe, Australia, the Middle East, the Philippines, and the United States. The company aims to address the global demand for accessible and user-friendly diagnostic solutions.


Partnerships and Government Collaborations

Neodocs boasts partnerships with leading pharmaceutical companies such as Cipla, Sun Pharma, and AstraZeneca, among others. These collaborations have played a vital role in standardizing test results across various health conditions, thereby enhancing the reliability and accessibility of the tests.


Moreover, Neodocs is collaborating closely with the governments of Maharashtra and Rajasthan to introduce digital testing solutions in remote areas of India, thereby bridging gaps in healthcare accessibility.


Empowering Preventive Healthcare

The founders of Neodocs—Nikunj Malpani, Anurag Meena, and Pratik Lodha—envision a healthcare landscape where emphasis is placed on proactive measures rather than reactive treatments. By enabling swift screening and diagnosis, Neodocs empowers healthcare providers to deliver timely interventions, ultimately shifting the healthcare paradigm towards preventive measures.


With over 200,000 test cards sold and support from over 4,000 doctors across India, Neodocs aims to scale its operations further, targeting sales of over 10 million test kits by the next year.


In conclusion, Neodocs' innovative approach to health diagnostics, coupled with its strategic partnerships and global expansion plans, positions the startup as a significant player in revolutionizing the accessibility and effectiveness of healthcare solutions worldwide.


留言


bottom of page